TW201634043A - Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof - Google Patents

Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof Download PDF

Info

Publication number
TW201634043A
TW201634043A TW104108491A TW104108491A TW201634043A TW 201634043 A TW201634043 A TW 201634043A TW 104108491 A TW104108491 A TW 104108491A TW 104108491 A TW104108491 A TW 104108491A TW 201634043 A TW201634043 A TW 201634043A
Authority
TW
Taiwan
Prior art keywords
water
shell
water chestnut
chestnut shell
extract
Prior art date
Application number
TW104108491A
Other languages
Chinese (zh)
Other versions
TWI546085B (en
Inventor
呂尙謙
Original Assignee
嘉藥學校財團法人嘉南藥理大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 嘉藥學校財團法人嘉南藥理大學 filed Critical 嘉藥學校財團法人嘉南藥理大學
Priority to TW104108491A priority Critical patent/TWI546085B/en
Application granted granted Critical
Publication of TWI546085B publication Critical patent/TWI546085B/en
Publication of TW201634043A publication Critical patent/TW201634043A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is related to an aqueous extract liquid of red water calltrop (Trapa bicornis var. taiwanensis (Nakai) shell, a method of producing the same and applications thereof. The red water calltrop shells are extracted by a thermal reflux extraction in water at pH 7.0 under 100 DEG C for no more than 3 hours, followed by removal of insolubles of the crude extract of the red water calltrop shells, thereby obtaining the aqueous extract liquid of red water calltrop shells. The aqueous extract liquid of red water calltrop shells can inhibit activities of matrix metalloproteinase-2 (MMP-2) and MMP-9, so as to be applied on a composition for external use on the skin or a medicinal composition.

Description

菱角殼水萃取液及其製造方法與應用 Water chestnut shell water extract, manufacturing method and application thereof

本發明是有關於一種植物萃取物及其製造方法,特別是有關於一種抑制基質金屬蛋白酶活性的菱角殼水萃取液及其製造方法與應用。 The invention relates to a plant extract and a preparation method thereof, in particular to an aqueous extract of water chestnut shell which inhibits the activity of matrix metalloproteinase, a preparation method and application thereof.

菱角是台灣南部的重要經濟作物。在台灣南部,菱角有兩個常見的品種,依其果實的尖角數量多寡,可概分為雙角菱(又名二角菱、野菱)及四角菱(又名四角格菱),而雙角菱中又以(Trapa bicornis)、台灣菱(Trapa bicornis var.taiwanensis(Nakai))為較常見的品種。台灣菱又名紅菱,為千屈菜科(Lythraceae)菱亞科(Trapaceae)菱屬(Trapa)之一年生浮水草本植物。目前在台南官田地區有大面積栽種。 Water chestnut is an important cash crop in southern Taiwan. In the southern part of Taiwan, there are two common varieties of water chestnuts. According to the number of sharp corners of the fruit, they can be divided into double-angled diamonds (also known as two-horned diamonds, wild diamonds) and four-angled diamonds (also known as four-pointed diamonds). In the double-angled ridge, Trapa bicornis and Trapa bicornis var. taiwanensis (Nakai) are the more common varieties. Taiwan Hung Ling Ling, also known as Lythraceae (Lythraceae) Link subfamily (Trapaceae) Trapa (Trapa) of floating annual herb. Currently, there is a large area planted in the Guantian area of Tainan.

菱角仁(果肉)富含澱粉質、脂肪、蛋白質、多種維生素及礦物質等成分,已知具有利尿通乳、止消渴、清暑益氣、解酒毒等功效。在菱角仁的生產過程中,菱角殼為菱角之副產物,過去普遍被當作農業廢棄物。 It is rich in starch, fat, protein, multivitamins and minerals. It is known to have the effects of diuretic through milk, anti-thirst, clearing heat and qi and hangover. In the production process of the water chestnut kernel, the water chestnut shell is a by-product of the water chestnut, which was widely used as agricultural waste in the past.

近年來有關菱角殼萃取物的研究,大多以醇類或者醇類水溶液萃取菱角殼,所得的菱角殼萃取物的生物活性例如抗氧化、抗菌、抑制脂解酶(lipase)、具有angiotensin-converting enzyme(ACE)之抑制效果及肝臟保護作用。惟以醇類或者醇類水溶液萃取菱角殼耗時較長,萃取後的成分較為複雜,若需進一步純化特定用途之特定成份,其製程步驟較繁瑣、製程時間較長且成本較高。 In recent years, most studies on the extract of the water chestnut shell have extracted the water chestnut shell with an aqueous solution of alcohol or alcohol, and the biological activity of the obtained water chestnut shell extract such as antioxidation, antibacterial, lipase inhibiting lipase, and angiotensin-converting enzyme (ACE) inhibition effect and liver protection. However, it takes a long time to extract the water chestnut shell with an alcohol or alcohol aqueous solution, and the extracted components are complicated. If further purification of specific components for a specific use is required, the process steps are cumbersome, the process time is long, and the cost is high.

有鑑於此,亟需提供一種再利用菱角殼的方法,以簡化習知製程步驟、縮短製程時間,以提升菱角殼的經濟價值。 In view of this, it is urgent to provide a method for reusing the water chest shell to simplify the conventional process steps and shorten the process time to improve the economic value of the water chest shell.

因此,本發明之一態樣是在提供一種菱角殼水萃取液之製造方法,其利用單步驟熱迴流萃取步驟以及固液分離步驟萃取紅菱(Trapa bicornis var.taiwanensis(Nakai))殼,以獲得菱角殼水萃取液。 Therefore, one aspect of the present invention provides a method for producing a water extract of a water chestnut shell, which extracts a shell of Trapa bicornis var. taiwanensis (Nakai) by a single-step hot reflux extraction step and a solid-liquid separation step. A water extract of the water chestnut shell is obtained.

其次,本發明之另一態樣是在提供一種菱角殼水萃取液,其係利用上述之方法而製得。 Next, another aspect of the present invention provides a water extract of a water chestnut shell which is obtained by the above method.

再者,本發明之另一態樣是在提供一種體外抑制基質金屬蛋白酶之方法,其利用含有上述之菱角殼水萃取液之組成物於體外處理動物細胞,以抑制動物細胞之第二型基質金屬蛋白酶(matrix metalloproteinase-2;MMP-2)及/或第九型基質金屬蛋白酶(MMP-9)的活性。 Furthermore, another aspect of the present invention provides a method for inhibiting a matrix metalloproteinase in vitro, which comprises treating a plant cell in vitro with a composition comprising the above-mentioned water extract of water chestnut shell to inhibit a second type matrix of animal cells. Activity of metalloproteinase-2 (MMP-2) and/or ninth matrix metalloproteinase (MMP-9).

根據本發明之上述態樣,提出一種菱角殼水萃 取液之製造方法。在一實施例中,此方法包含進行單步驟(one-step)熱迴流萃取步驟,利用100℃以及pH 7.0之水處理紅菱角殼不超過3小時,以獲得粗萃物。接著,進行固液分離步驟,以去除上述粗萃物之不溶物,藉此獲得菱角殼水萃取液。 According to the above aspect of the invention, a water chestnut shell extraction is proposed. The method of manufacturing the liquid. In one embodiment, the method comprises performing a one-step hot reflux extraction step of treating the red cube shell with water at 100 ° C and pH 7.0 for no more than 3 hours to obtain a crude extract. Next, a solid-liquid separation step is performed to remove the insoluble matter of the above crude extract, thereby obtaining a water extract of the water chestnut shell.

依據本發明一實施例,上述之紅菱角殼與該水之一重量體積比(w/v;g/mL)可例如為1:5至1:20,然以1:5至1:10為較佳。 According to an embodiment of the invention, the weight-to-volume ratio (w/v; g/mL) of the red cube shell and the water may be, for example, 1:5 to 1:20, but 1:5 to 1:10. Preferably.

依據本發明一實施例,在上述單步驟熱迴流萃取步驟之前,更可選擇性包含對紅菱角殼進行乾燥處理,以及對經乾燥之紅菱角殼進行研磨處理,以獲得菱角殼乾燥粉末。 According to an embodiment of the present invention, before the single-step hot reflux extraction step, the red horn shell may be selectively dried, and the dried red horn shell is ground to obtain a water chestnut dry powder.

根據本發明之另一態樣,提出一種菱角殼水萃取液,其係利用上述之方法所製得。在一個例子中,所得之菱角殼水萃取液具有抑制第二型基質金屬蛋白酶(MMP-2)及/或第九型基質金屬蛋白酶(MMP-9)之活性。 According to another aspect of the present invention, there is provided a water extract of water chestnut shell which is obtained by the above method. In one example, the resulting water extract of the water chestnut shell has activity to inhibit matrix metalloproteinase-2 (MMP-2) and/or matrix metalloproteinase (MMP-9).

根據本發明之又一態樣,提出一種體外抑制基質金屬蛋白酶之方法,其特徵在於利用含有上述之菱角殼水萃取液之組成物於體外處理動物細胞,以抑制動物細胞之第二型基質金屬蛋白酶(MMP-2)及/或第九型基質金屬蛋白酶(MMP-9)的活性。 According to still another aspect of the present invention, a method for inhibiting a matrix metalloproteinase in vitro is provided, which comprises treating a plant cell in vitro with a composition comprising the above-mentioned water extract of a water chestnut shell to inhibit a second type of matrix metal of the animal cell. Activity of protease (MMP-2) and/or ninth matrix metalloproteinase (MMP-9).

應用本發明之菱角殼水萃取液及其製造方法,其利用單步驟熱迴流萃取步驟以及固液分離步驟萃取紅菱角殼,由此所得之菱角殼水萃取液經體外實驗證明具有抑制 第二型基質金屬蛋白酶及/或第九型基質金屬蛋白酶之活性,可應用於皮膚外用組成物或醫藥組成物。 The water chestnut water extract of the present invention and the method for producing the same are characterized in that the red water chestnut shell is extracted by a single-step hot reflux extraction step and a solid-liquid separation step, and the obtained water extract of the water chestnut shell has been inhibited by an in vitro experiment. The activity of the second type matrix metalloproteinase and/or the ninth type matrix metalloproteinase can be applied to a skin external composition or a pharmaceutical composition.

為讓本發明之上述和其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之詳細說明如下:〔圖1〕係繪示根據本發明一實施例之菱角殼水萃取液之細胞存活率的直條圖。 The above and other objects, features, advantages and embodiments of the present invention will become more <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; A bar graph of cell viability.

〔圖2至圖4〕係顯示本發明數個實施例之利用不同濃度的菱角殼水萃取液以不同時間培養纖維母細胞後之明膠酶譜電泳分析圖。 [Fig. 2 to Fig. 4] Fig. 2 to Fig. 4 are diagrams showing gelatin zymogram analysis of the fibroblasts cultured at different concentrations using different concentrations of water chestnut aqueous extracts in several embodiments of the present invention.

〔圖5至圖7〕係顯示本發明數個實施例之利用不同濃度的菱角殼水萃取液以不同時間與透明質酸酶反應後之透明質酸酶譜電泳分析圖。 [Fig. 5 to Fig. 7] Fig. 5 to Fig. 7 are diagrams showing the analysis of hyaluronic acid spectroscopy electrophoresis after reacting different concentrations of water chestnut aqueous extracts with hyaluronidase at different times in several embodiments of the present invention.

承前所述,本發明提供一種菱角殼水萃取液及其製造方法,其利用單步驟熱迴流萃取步驟以及固液分離步驟萃取菱角殼。 As described above, the present invention provides a water chestnut shell water extract and a method for producing the same, which utilize a single-step hot reflux extraction step and a solid-liquid separation step to extract a water chestnut shell.

本發明此處所稱之「菱角殼水萃取液」,係專指由台灣原生種的紅菱(Trapa bicornis var.taiwanensis(Nakai))在加工過程被棄的菱角殼,經水於短時間單步驟熱迴流萃取步驟之粗萃液,再去除其不溶物後所得者。在一實施例中,本發明使用之紅菱角殼為台南官田產區採收者, 實質上並不含上述以外的品種。其次,本發明僅使用紅菱角殼進行萃取,實質上並不含菱角仁。在另一實施例中,本發明使用之紅菱角殼可選擇性經過習知乾燥、研磨等處理。在又一實施例中,本發明使用之紅菱角殼之含水量可例如為3.0重量百分比至10.0重量百分比。 The term "water chestnut shell water extract" as used herein refers to a water chestnut shell that has been discarded by the Taiwan native species, Trapa bicornis var. taiwanensis (Nakai), and is subjected to water in a short time. The crude extract of the hot reflux extraction step is removed after the insoluble matter is removed. In one embodiment, the red water chest shell used in the present invention is a harvester of the Tainan Guantian production area, and substantially does not contain the varieties other than the above. Secondly, the present invention uses only the red horn shell for extraction, and does not substantially contain the horn kernel. In another embodiment, the red cube shell used in the present invention may optionally be subjected to conventional drying, grinding, and the like. In still another embodiment, the water content of the red horn shell used in the present invention may be, for example, 3.0% by weight to 10.0% by weight.

在此說明的是,倘若使用上述產區以外品種或其含水量在上述範圍以外之紅菱角殼,則後續萃取所得之菱角殼水萃取液無法達到所要求於體外抑制動物細胞之第二型基質金屬蛋白酶及/或第九型基質金屬蛋白酶的活性又具低細胞毒性。 It is stated that if a variety other than the above-mentioned production area or a water chestnut shell having a water content outside the above range is used, the water extract of the water chestnut shell obtained by subsequent extraction cannot reach the second type substrate which is required to inhibit animal cells in vitro. The activity of metalloproteinases and/or ninth type matrix metalloproteinases is also low cytotoxic.

本發明此處所稱之「低細胞毒性」,係專指以下製得的菱角殼水萃取液與纖維母細胞培養24小時至48小時後,細胞存活率仍高於60%的情形。 The term "low cytotoxicity" as used herein refers to a situation in which the cell viability is still higher than 60% after 24 to 48 hours of culture of the water chestnut water extract prepared from the following water cells.

前述的菱角殼水萃取液可利用以下方法製得。在一實施例中,此方法可先提供紅菱角殼,例如台南官田產區採收者。在一例示中,前述之紅菱角殼之含水量可例如為3.0重量百分比至10.0重量百分比,至於菱角殼之含水量可利用習知的乾燥步驟,例如自然風乾,或於例如約50℃之烘箱內烘乾,以調整至所需的含水量。 The aforementioned water extract of the water chestnut shell can be obtained by the following method. In an embodiment, the method may first provide a red horn shell, such as a harvester in the Tainan Guantian production area. In one example, the water content of the aforementioned red water chest shell may be, for example, 3.0% by weight to 10.0% by weight, and the water content of the water chest shell may be dried by a conventional drying method, such as natural air drying, or in an oven of, for example, about 50 ° C. Dry inside to adjust to the desired water content.

接著,進行單步驟熱迴流萃取步驟,利用100℃以及pH 7.0之水處理紅菱角殼不超過3小時,以獲得粗萃物。在一實施例中,上述單步驟熱迴流萃取步驟之處理時間較短,以不超過3小時為宜,然以1小時至3小時為較佳。倘若單步驟熱迴流萃取步驟之處理時間不足1小時,則後續所 得菱角殼水萃取液的有效成分含量會不足,又若單步驟熱迴流萃取步驟之處理時間超過3小時,則後續所得菱角殼水萃取液會含有其他不想要的副成份,皆無法達到所要求於體外抑制動物細胞之第二型基質金屬蛋白酶及/或第九型基質金屬蛋白酶的活性又具低細胞毒性。 Next, a one-step hot reflux extraction step was carried out, and the red water chestnut shell was treated with water at 100 ° C and pH 7.0 for no more than 3 hours to obtain a crude extract. In one embodiment, the single-step hot reflux extraction step has a shorter treatment time of not more than 3 hours, preferably 1 hour to 3 hours. If the processing time of the single-step hot reflux extraction step is less than one hour, then the subsequent The content of the active ingredient of the water extract of the water chestnut shell will be insufficient, and if the treatment time of the single-step hot reflux extraction step exceeds 3 hours, the subsequent water extract of the water chestnut shell will contain other unwanted sub-components, which cannot meet the requirements. The activity of the second type matrix metalloproteinase and/or the ninth type matrix metalloproteinase which inhibits animal cells in vitro is also low in cytotoxicity.

在一例子中,上述紅菱角殼與水之重量體積比(w/v;g/mL)可例如為1:5至1:20,然以1:5至1:10為較佳,又以1:5至1:8為更佳。 In an example, the weight-to-volume ratio (w/v; g/mL) of the above-mentioned red cube shell to water may be, for example, 1:5 to 1:20, but preferably 1:5 to 1:10, and 1:5 to 1:8 is better.

在上述單步驟熱迴流萃取步驟之前,亦可選擇性利用習知乾燥步驟將上述紅菱角殼乾燥後,再加工磨成粉末,以進行後續之單步驟熱迴流萃取步驟。 Before the single-step hot reflux extraction step, the above-mentioned red water chest shell may be selectively dried by a conventional drying step, and then processed into a powder to carry out a subsequent single-step hot reflux extraction step.

補充說明的是,上述單步驟熱迴流萃取步驟僅需利用習知熱迴流設備進行,無需合併其他輔助方式(例如攪拌、超音波震盪)。 It should be added that the above-mentioned single-step hot reflux extraction step only needs to be carried out by using a conventional heat reflux device, and it is not necessary to incorporate other auxiliary methods (for example, stirring, ultrasonic vibration).

在單步驟熱迴流萃取步驟之後,對粗萃物進行固液分離步驟,以去除上述粗萃物之不溶物,藉此獲得菱角殼水萃取液,其中所得菱角殼水萃取液之固形物的含量一般為4.1重量百分比至6.5重量百分比,然以4.5重量百分比至6.0重量百分比為較佳。 After the single-step hot reflux extraction step, the crude extract is subjected to a solid-liquid separation step to remove the insoluble matter of the crude extract, thereby obtaining a water extract of the water chestnut shell, wherein the solid content of the water extract of the water chestnut shell is obtained. It is generally from 4.1% by weight to 6.5% by weight, and preferably from 4.5% by weight to 6.0% by weight.

另需補充說明的是,有關固液分離及乾燥步驟等,可使用任何習知方式進行,不限於上述所舉,且為本發明所屬技術領域中任何具有通常知識者所熟知,故不另外逐一贅述。 It should be additionally noted that the solid-liquid separation and drying steps and the like may be carried out by any conventional means, and are not limited to the above, and are well known to those of ordinary skill in the art to which the present invention pertains, so that they are not separately Narration.

在一實施例中,利用含有上述之菱角殼水萃取 液的組成物於體外處理生物材料時,可於體外抑制第二型基質金屬蛋白酶及/或第九型基質金屬蛋白酶的活性且具低細胞毒性。在一例子中,上述生物材料可例如為動物細胞、酵素或蛋白質,動物細胞之來源可例如為小鼠,而動物細胞可例如為纖維母細胞。在另一例子中,上述菱角殼水萃取液確實可於體外抑制第二型基質金屬蛋白酶及/或第九型基質金屬蛋白酶的活性且具低細胞毒性。 In one embodiment, the water extraction is carried out using a water chestnut shell containing the above The composition of the liquid inhibits the activity of the second type matrix metalloproteinase and/or the matrix metalloproteinase type 9 in vitro and has low cytotoxicity when the biological material is treated in vitro. In one example, the biological material may be, for example, an animal cell, an enzyme or a protein, the source of the animal cell may be, for example, a mouse, and the animal cell may be, for example, a fibroblast. In another example, the water extract of the water chestnut shell can indeed inhibit the activity of the second type matrix metalloproteinase and/or the matrix metalloproteinase type 9 in vitro and has low cytotoxicity.

第二型基質金屬蛋白酶(MMP-2)以及第九型基質金屬蛋白酶(MMP-9)均為明膠蛋白酶(gelatinase),亦同屬於基質金屬蛋白酶(MMPs)家族的一份子,具有分解膠原和細胞外基質(extracelluar matrix;ECM)的能力。MMP-2大量存在於正常的纖維母細胞、內皮細胞、上皮細胞與轉型細胞(transformed cells),而MMP-9則存在於白血球與轉性細胞。本發明利用明膠酶電泳分析方法,證明菱角殼水萃取液可抑制MMP-2與MMP-9的酵素活性且具低細胞毒性。 The second type of matrix metalloproteinase (MMP-2) and the ninth type of matrix metalloproteinase (MMP-9) are gelatinases, which are also part of the matrix metalloproteinases (MMPs) family, which have collagen and cells. The ability of an extracelluar matrix (ECM). MMP-2 is abundantly present in normal fibroblasts, endothelial cells, epithelial cells and transformed cells, while MMP-9 is present in white blood cells and transfected cells. The invention utilizes gelatinase electrophoresis analysis method to prove that the water extract of the water chestnut shell can inhibit the enzyme activity of MMP-2 and MMP-9 and has low cytotoxicity.

在此說明的是,由於上述所得之菱角殼粗萃物與菱角殼水萃取液的生物活性極佳,且具低細胞毒性,因此可應用於製備各種皮膚外用組成物或醫藥組成物,例如於化妝品、乳液、面膜、藥皂、沐浴乳、藥膏、噴劑等,惟上述應用僅為例示,本發明不限於此處所舉。 It is explained that, since the above-mentioned crude extract of the water chestnut shell and the water extract of the water chestnut shell have excellent biological activity and low cytotoxicity, they can be applied to prepare various skin external compositions or pharmaceutical compositions, for example, Cosmetics, lotions, masks, medicated soaps, body washes, ointments, sprays, etc., but the above applications are merely illustrative, and the invention is not limited thereto.

以下利用數個實施例以說明本發明之應用,然其並非用以限定本發明,本發明技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與 潤飾。 The following examples are used to illustrate the application of the present invention, and are not intended to limit the present invention. Those skilled in the art can make various changes without departing from the spirit and scope of the present invention. Retouching.

製備菱角殼水萃取液Preparation of water chestnut shell water extract

實施例Example

首先如表1所示,收集台南官田產區當年採收的紅菱在加工過程被棄的菱角殼,經自然風乾後,使菱角殼之含水量控制在3重量百分比至10重量百分比。將紅菱角殼研磨成粉體後,接著將20公克(g)之紅菱角殼粉體與160mL之水加入熱迴流設備之圓底燒瓶中,在100℃以及pH 7.0之水中進行熱迴流萃取。經3小時後,隨即利用濾材進行初步過濾、抽氣過濾以及離心(8000rpm,20分鐘)進行固液分離步驟,以去除上述粗萃物之不溶物,藉此獲得菱角殼水萃取液並保存於-20℃備用,其中實施例所得之菱角殼水萃取液之固形物的含量為5.7重量百分比。 First, as shown in Table 1, the water chestnut shells that were harvested during the processing of the red diamond harvested in the Tainan Guantian production area were collected, and after natural air drying, the water content of the water chestnut shell was controlled to be 3 to 10 weight percent. After the red horn shell was ground into a powder, 20 g (g) of the red stalk shell powder and 160 mL of water were placed in a round bottom flask of a hot reflux apparatus, and subjected to hot reflux extraction at 100 ° C and water of pH 7.0. After 3 hours, the filtrate was subjected to preliminary filtration, suction filtration, and centrifugation (8000 rpm, 20 minutes) to carry out a solid-liquid separation step to remove the insoluble matter of the above crude extract, thereby obtaining a water extract of the water chestnut shell and storing it in The content of the solid matter of the water extract of the water chestnut shell obtained in the example was 5.7 weight%.

評估方式Evaluation method

以下利用數項試驗評估實施例的菱角殼水萃取液抑制基質金屬蛋白酶之功效,其中有關菱角殼水萃取液之濃度,是以實施例所得之菱角殼水萃取液之原液濃度為100%。 The effect of inhibiting matrix metalloproteinase by the water extract of the water chestnut shell of the examples was evaluated by several tests. The concentration of the water extract of the water chestnut shell was 100% of the stock solution of the water extract of the water chestnut shell obtained in the examples.

1.細胞解凍活化1. Thawing and activation of cells

將3T3細胞T3小鼠胚胎纖維母細胞(購自食品工業研究所之生物資源保存及研究中心,寄存編號為BCRC 60071;ATCC寄存編號為CCL-92)的冷凍小瓶(含有抗凍 成份DMSO)自液態氮桶內取出,迅速置於37℃水浴槽中,待其充分解凍後,將細胞懸浮液加入含有新鮮培養液之培養皿中,置於37℃保持溼度的細胞培養箱(含5.0% CO2)中培養30分鐘。待細胞貼覆後,移除含有DMSO之培養基,再補入4mL新鮮培養基繼續培養2~3天。上述新鮮培養液包含杜貝可改良之伊格氏培養液(Dulbecco's Modified Eagle's Medium;DMEM;Biowest,USA),添加10體積百分比的新生牛血清(newborn calf serum;NCS;Gibco,USA)以及1體積百分比的三合一抗生素(含有盤尼西林、鏈黴素與兩性黴素,penicillin/streptomycin/amphotericin;pen-strep-ampho;Gibco,USA)。 3T3 cell T3 mouse embryonic fibroblasts (purchased from the Bioresource Conservation and Research Center of the Food Industry Research Institute, registration number BCRC 60071; ATCC accession number CCL-92) frozen vials (containing antifreeze DMSO) The liquid nitrogen drum was taken out and quickly placed in a 37 ° C water bath. After it was fully thawed, the cell suspension was added to a petri dish containing fresh culture solution and placed in a cell culture incubator at 37 ° C (containing 5.0% CO). 2) for 30 minutes. After the cells were pasted, the medium containing DMSO was removed, and 4 mL of fresh medium was added to continue the culture for 2 to 3 days. The above fresh culture solution contains Dulbecco's Modified Eagle's Medium (DMEM; Biowest, USA), 10 volume percent of newborn calf serum (NCS; Gibco, USA) and 1 volume. Percentage of three-in-one antibiotics (containing penicillin, streptomycin and amphotericin, penicillin/streptomycin/amphotericin; pen-strep-ampho; Gibco, USA).

待細胞生長至約九成滿度時,移除培養液,加入1mL之1X PBS緩衝液(Biowest,USA)潤洗細胞表面後,移除PBS緩衝液,再加入1mL之胰蛋白酶(trypsin-EDTA;Gibco,USA)使細胞脫落。而後,隨即將所需數量之細胞加入4mL之上述新鮮培養基中,置於37℃的細胞培養箱(含5.0% CO2)中培養2~3天後,進行繼代培養。 When the cells were grown to about 90% fullness, remove the culture solution, add 1 mL of IX PBS buffer (Biowest, USA) to rinse the cell surface, remove the PBS buffer, and add 1 mL of trypsin (trypsin-EDTA). ; Gibco, USA) causes the cells to fall off. Then, the desired number of cells were added to 4 mL of the above fresh medium, and cultured in a 37 ° C cell culture incubator (containing 5.0% CO 2 ) for 2 to 3 days, followed by subculture.

有關繼代培養可使用任何習知方式進行,此為本發明所屬技術領域中任何具有通常知識者所熟知,不另贅述。 Subculture may be carried out using any conventional means, which is well known to those of ordinary skill in the art to which the invention pertains, and will not be further described.

2.評估細胞毒性2. Evaluation of cytotoxicity

此項評估是利用MTT[3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide],進 行細胞毒性的測試。MTT為四唑鹽(tetrazolium salt),經細胞內粒腺體琥珀酸去氫酶(succinate dehydrogenase)分解後,由透明無色產生藍色甲臢(formazan)晶體。死細胞則會因為細胞內粒腺體去氫酶失去活性而不能產生藍色結晶,故可由藍色結晶的多寡判斷細胞的存活。 This evaluation is based on MTT[3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide] Test for cytotoxicity. MTT is a tetrazolium salt, which is decomposed by intracellular granule gland succinate dehydrogenase to produce blue formazan crystals from transparent colorless. Dead cells can not produce blue crystals because the intracellular granule dehydrogenase loses activity, so the survival of cells can be judged by the amount of blue crystals.

在測定前,先利用無菌技術將100μL之3T3細胞(細胞密度為5×104cell/well)接種於96孔(well)微量培養盤(microplate)中,置於37℃保持溼度的細胞培養箱(含5.0% CO2)培養24小時。接著,移除培養液,以100μL/well之PBS緩衝液清洗細胞表面後並移除,再加入100μL/well之細胞培養液及含有不同濃度之菱角殼水萃取液(實驗組)或不含菱角殼水萃取液(控制組),培養24、48小時。之後移除溶液,分別加入100μL/well之0.5mg/mL MTT溶液,於37℃保持溼度的細胞培養箱(含5.0% CO2)培養3小時後移除溶液,再加入100μL/well之DMSO溶解甲臢結晶。空白組的孔中(不含細胞)則加入同體積的DMSO。之後,利用ELISA reader於波長540nm偵測吸光值,並以控制組細胞於540nm之吸光值作為100%,其結果如圖1所示。 Prior to the assay, 100 μL of 3T3 cells (cell density 5×10 4 cell/well) were inoculated into 96 well microplates by aseptic technique and placed in a cell culture incubator at 37 ° C to maintain humidity. (containing 5.0% CO 2 ) for 24 hours. Next, the culture solution was removed, and the cell surface was washed with 100 μL/well of PBS buffer and removed, and then 100 μL/well of the cell culture medium and the water extract containing different concentrations of the water chestnut shell (experimental group) or without the water chestnut were added. Shell water extract (control group), cultured for 24, 48 hours. Then remove the solution, add 100 μL/well of 0.5 mg/mL MTT solution, incubate in a cell culture incubator (containing 5.0% CO 2 ) maintained at 37 ° C for 3 hours, remove the solution, and add 100 μL/well of DMSO to dissolve. Hyperthyroidism crystallizes. The same volume of DMSO was added to the wells of the blank group (without cells). Thereafter, the absorbance was detected at a wavelength of 540 nm by an ELISA reader, and the absorbance at 540 nm of the control group was taken as 100%, and the results are shown in FIG.

請參閱圖1,其係顯示本發明一實施例之利用不同濃度的菱角殼水萃取液以不同時間培養纖維母細胞後之細胞存活率的直條圖。在圖1中,每組數據之樣本數至少為3個(n≧3)。 Please refer to FIG. 1 , which is a bar graph showing the cell survival rate of fibroblasts cultured at different times using different concentrations of water chestnut shell water extract according to an embodiment of the present invention. In Figure 1, the number of samples per set of data is at least three (n ≧ 3).

由圖1結果可知,利用0.25%、0.50%、1.00%、2.50%的實施例之菱角殼水萃取液培養3T3纖維母細胞24 小時後,細胞存活率仍高於60%。利用0.25%、0.50%、1.00%的實施例之菱角殼水萃取液培養3T3纖維母細胞48小時後,細胞存活率仍高於60%。代表菱角殼水萃取液對細胞毒性較低。 As can be seen from the results of Fig. 1, 3T3 fibroblasts were cultured using 0.25%, 0.50%, 1.00%, 2.50% of the water extract of the water chestnut shell of the examples. After an hour, cell viability was still above 60%. After incubating 3T3 fibroblasts with 0.25%, 0.50%, and 1.00% of the water extract of the water chestnut shell of the example for 48 hours, the cell survival rate was still higher than 60%. The water extract of the water chestnut shell is low in cytotoxicity.

2.評估菱角殼水萃取液對基質金屬蛋白酶之活性抑制效果2. To evaluate the inhibitory effect of water extract of water chestnut shell on matrix metalloproteinase

第二型基質金屬蛋白酶(MMP-2)以及第九型基質金屬蛋白酶(MMP-9)均為明膠蛋白酶(gelatinase),亦同屬於基質金屬蛋白酶(MMPs)家族的一份子,具有裂解膠原和細胞外基質(extracelluar matrix;ECM)的能力。MMP-2大量存在於正常的纖維母細胞、內皮細胞、上皮細胞與轉型細胞(transformed cells),而MMP-9則存在於白血球與轉型細胞。利用明膠酶電泳分析方法,可分離MMP-2(MW為64kDa)與MMP-9(MW為86kDa)、原MMP-9(pro-MMP-9,MW為92kDa)並同時檢測三者的酵素活性。以下利用實施例之菱角殼水萃取液與細胞進行培養,並利用明膠酶電泳分析方法評估菱角殼水萃取液對基質金屬蛋白酶之活性抑制效果。 The second type of matrix metalloproteinase (MMP-2) and the ninth type of matrix metalloproteinase (MMP-9) are gelatinases, which are also part of the matrix metalloproteinases (MMPs) family, which have cleavage of collagen and cells. The ability of an extracelluar matrix (ECM). MMP-2 is abundantly present in normal fibroblasts, endothelial cells, epithelial cells and transformed cells, while MMP-9 is present in white blood cells and transformed cells. Using gelatinase electrophoresis analysis, MMP-2 (MW 64kDa) and MMP-9 (MW 86kDa), original MMP-9 (pro-MMP-9, MW 92kDa) can be isolated and the enzyme activities of the three can be detected simultaneously. . The water extract of the water chestnut shell of the example was cultured with the cells, and the gelatinase electrophoresis analysis method was used to evaluate the inhibitory effect of the water extract of the water chestnut shell on the matrix metalloproteinase.

2.1 利用實施例之菱角殼水萃取液處理細胞2.1 Treatment of cells with the water extract of the water chestnut shell of the examples

3T3纖維母細胞經培養24小時或48小時後,利用添加不同濃度(0.25%、0.50%、1.00%、2.5%、5.00%、10.0%)之實施例之菱角殼水萃取液(實驗組)或等體積之無菌水(控制組,C)的細胞培養液,於37℃培養0小時、24小時或48小時。然後,取各組之細胞培養上清液,進行明膠 酶譜(gelatin zymography)電泳分析,以評估實施例的菱角殼水萃取液之MMP-2與MMP-9的活性抑制效果。 After cultured for 24 hours or 48 hours, 3T3 fibroblasts were treated with different concentrations (0.25%, 0.50%, 1.00%, 2.5%, 5.00%, 10.0%) of the water extract of the water chestnut shell (experimental group) or An equal volume of sterile water (Control Group, C) cell culture medium was incubated at 37 ° C for 0 hours, 24 hours or 48 hours. Then, take the cell culture supernatant of each group and perform gelatin. The gelatin zymography electrophoresis analysis was carried out to evaluate the inhibitory effect of MMP-2 and MMP-9 on the water extract of the water chestnut shell of the examples.

2.2 明膠酶譜之電泳分析2.2 Electrophoresis analysis of gelatin zymogram

製作凝膠時,首先製備含最終濃度1.0%之明膠(gelatin-type A,Sigma,USA)的10%硫酸十二酯鈉-聚丙烯胺凝膠(sodium dodecyl sulfate-polyacrylamide gel electrophoresis;SDS-PAGE)之分離膠體(separating gel)溶液,注入鑄膠模型(gel caster,BIO-RAD;spacer厚度為0.75mm)中,約八分滿後,於上層緩緩加入去離子水,靜置隔夜待膠體凝固。然後,製作焦集膠體(stacking gel),先倒除分離膠體上方之去離子水後,緩緩加入4%之SDS-PAGE之焦集膠體溶液,隨後插入電泳齒梳,於室溫下靜置至膠體凝結。上述各膠體的配製已為此技術領域中任何具有通常知識者所熟知,不另詳述。 When making the gel, first prepare 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) containing gelatin-type A (Sigma, USA) at a final concentration of 1.0%. Separating gel solution, injected into the cast rubber model (gel caster, BIO-RAD; spacer thickness 0.75mm), after about eight minutes, slowly add deionized water to the upper layer, and stand overnight to be colloidal solidification. Then, prepare a stacking gel, first remove the deionized water above the separation colloid, and then slowly add a 4% SDS-PAGE coke collecting colloid solution, then insert the electrophoresis tooth comb and let stand at room temperature. To colloid condensation. The formulation of each of the above colloids is well known to those of ordinary skill in the art and will not be described in detail.

待膠體完全凝固後,拔出電泳齒梳後,將鑄好的明膠-SDS-PAGE電泳膠片置於含有1X tank buffer(含25mM Tris、192mM glycine及0.1% SDS,pH 8.3)的電泳槽中。然後,將待測樣品與等體積之2倍濃縮追蹤染劑〔2X loading dye,含有溴酚藍(Bromophenol Blue,Amresco,USA)與甘油(J.T.Baker,USA)的混合溶液〕混合均勻,在每個焦集膠體的溝槽注入20μL之混合染劑的待測樣品,在80V電壓進行電泳,待膠片上的追蹤染劑離開堆疊膠體時,將電壓提高至100V進行電泳。待追蹤染劑移動到分離膠體底部後約40分鐘,結束電泳,取出明膠 -SDS-PAGE電泳膠片。 After the colloid was completely solidified, the electrophoresis comb was pulled out, and the cast gelatin-SDS-PAGE electrophoresis film was placed in an electrophoresis tank containing 1X tank buffer (containing 25 mM Tris, 192 mM glycine, and 0.1% SDS, pH 8.3). Then, the sample to be tested is mixed with an equal volume of 2 times concentrated dyeing agent [2X loading dye, a mixed solution containing Bromophenol Blue (Amresco, USA) and glycerol (JT Baker, USA)], A sample of the coke-colloid colloid was injected with 20 μL of the mixed sample of the dye, and electrophoresis was carried out at a voltage of 80 V. When the trace dye on the film left the stacked colloid, the voltage was raised to 100 V for electrophoresis. After the dye is moved to the bottom of the separation gel for about 40 minutes, the electrophoresis is finished, and the gelatin is taken out. -SDS-PAGE electrophoresis film.

之後,將明膠-SDS-PAGE電泳膠片利用清洗緩衝液(wash buffer;含0.05M Tris、0.1M NaCl及2.5% Triton X-100)在37℃搖晃清洗1小時後,依序利用反應緩衝液(reaction buffer;含0.05M Tris、0.1M NaCl、2.5% Triton X-100及0.1mM CaCl2)於室溫(10℃至40℃)搖晃反應20小時、利用固定緩衝液(fixation buffer;50%甲醇及12%醋酸)於室溫固定30分鐘、利用染色緩衝液(staining buffer;含0.25% Coomassie blue、40%甲醇及7%醋酸)於室溫染色10分鐘至30分鐘、以及利用褪染緩衝液(destaining buffer;含40%甲醇及7%醋酸)褪染1小時至2小時,直到透明的色帶(band)清晰可見為止。而後,利用玻璃紙封片固定於壓克力板上,放置室溫下自然風乾,其結果如圖2至圖4所示。 Thereafter, the gelatin-SDS-PAGE electrophoresis film was washed with a washing buffer (containing 0.05 M Tris, 0.1 M NaCl, and 2.5% Triton X-100) at 37 ° C for 1 hour, and then the reaction buffer was sequentially used ( Reaction buffer; containing 0.05M Tris, 0.1M NaCl, 2.5% Triton X-100 and 0.1 mM CaCl 2 ), shaking at room temperature (10 ° C to 40 ° C) for 20 hours, using fixing buffer (fixation buffer; 50% methanol And 12% acetic acid) fixed at room temperature for 30 minutes, stained with staining buffer (containing 0.25% Coomassie blue, 40% methanol and 7% acetic acid) for 10 minutes to 30 minutes at room temperature, and using the depletion buffer (destaining buffer; containing 40% methanol and 7% acetic acid) was allowed to fade for 1 hour to 2 hours until the transparent band was clearly visible. Then, it was fixed on an acrylic plate with a cellophane sheet, and left to stand at room temperature to be air-dried. The results are shown in Figs. 2 to 4 .

請參閱圖2至圖4,其係顯示本發明數個實施例之利用不同濃度的菱角殼水萃取液以不同時間培養纖維母細胞後之明膠酶譜電泳分析圖。在圖2至圖4中,第1道及第9道代表蛋白質標記(PageRulerTM Prestained Protein Ladder#26616,Thermo,USA;M),第2道代表控制組細胞培養0小時(C0),第5道代表控制組細胞培養24小時(C24)的結果,第8道代表控制組細胞培養48小時(C48)的結果,第3、4道代表實驗組細胞培養24小時的結果,第6、7道代表實驗組細胞培養48小時的結果。 Please refer to FIG. 2 to FIG. 4 , which are diagrams showing the gelatin zymogram analysis of the fibroblasts cultured at different concentrations using different concentrations of water chestnut aqueous extracts in several embodiments of the present invention. In FIG. 2 to FIG. 4, lane 1 represents a protein marker and 9 (PageRuler TM Prestained Protein Ladder # 26616 , Thermo, USA; M), lane 2 representing the control group were cultured 0 hours (C 0), the first 5 lanes represent the results of cell culture for 24 hours (C 24 ), lane 8 represents the results of control group cell culture for 48 hours (C 48 ), lanes 3 and 4 represent experimental group cell culture for 24 hours, phase 6 Seven lanes represent the results of cell culture in the experimental group for 48 hours.

由圖2的結果可知,利用0.25%的實施例之菱角 殼水萃取液培養纖維母細胞24小時後,即開始具有抑制MMP-2與MMP-9活性的效果。隨著菱角殼水萃取液之濃度以及培養時間的增加,抑制MMP-2與MMP-9活性的效果就越明顯,如圖2至圖4的結果所示。相較之下,控制組細胞的MMP-2與MMP-9活性並未受到抑制。因此,圖2至圖4的結果證明,實施例之菱角殼水萃取液確實可於體外抑制細胞的第二型基質金屬蛋白酶及第九型基質金屬蛋白酶的活性。 It can be seen from the results of FIG. 2 that the angle of 0.25% of the embodiment is utilized. The shell water extract cultured the fibroblasts for 24 hours, and began to have an effect of inhibiting the activities of MMP-2 and MMP-9. With the increase of the concentration of the water extract of the water chestnut shell and the incubation time, the effect of inhibiting the activity of MMP-2 and MMP-9 is more obvious, as shown by the results of FIGS. 2 to 4. In contrast, MMP-2 and MMP-9 activities in the control group cells were not inhibited. Therefore, the results of FIGS. 2 to 4 demonstrate that the water extract of the water chestnut shell of the examples can inhibit the activity of the second type matrix metalloproteinase and the matrix type metalloproteinase of the cells in vitro.

3.評估菱角殼水萃取液對透明質酸酶之活性抑制效果3. To evaluate the inhibitory effect of water extract of water chestnut shell on hyaluronidase

透明質酸為一種黏多醣體,對於骨關節中軟骨的保護相當重要。透明質酸酶會分解透明質酸、解軟骨素、葡萄糖胺等。利用透明質酸酶電泳分析方法,可檢測透明質酸酶的酵素活性。以下利用實施例之菱角殼水萃取液與透明質酸酶反應後,並利用透明質酸酶電泳分析方法評估菱角殼水萃取液對透明質酸酶之活性抑制效果。 Hyaluronic acid is a mucopolysaccharide that is important for the protection of cartilage in bone and joint. Hyaluronidase decomposes hyaluronic acid, chondroitin, glucosamine, and the like. The hyaluronidase enzyme activity can be detected by hyaluronidase electrophoresis. After the reaction with the hyaluronidase was carried out by using the water extract of the water chestnut shell of the example, the hyaluronidase aqueous extract was used to evaluate the inhibitory effect of the water extract of the water chestnut shell on the hyaluronidase activity.

3.1 利用實施例之菱角殼水萃取液與透明質酸酶反應3.1 Using the water extract of the water chestnut shell of the embodiment and reacting with hyaluronidase

將不同濃度(0.25%、0.50%、1.00%、2.5%、5.00%、10.0%)之實施例之菱角殼水萃取液(實驗組)或等體積之無菌水(控制組,C)與透明質酸酶(Hyaluronidase,Creative Biomart,USA)混合後,隨即於37℃反應0小時、24小時或48小時。然後,取各組之反應物,進行透明質酸酶譜電泳分析,以評估實施例的菱角殼水萃取液對透明質酸酶的活性抑制效果。 Different concentrations (0.25%, 0.50%, 1.00%, 2.5%, 5.00%, 10.0%) of the water extract of the water chestnut shell (experimental group) or an equal volume of sterile water (control group, C) and hyaluronic acid After mixing with an acidase (Hyaluronidase, Creative Biomart, USA), it was then reacted at 37 ° C for 0 hours, 24 hours or 48 hours. Then, the reactants of each group were taken and analyzed by hyaluronidase spectroscopy to evaluate the inhibitory effect of the water extract of the water chestnut shell of the examples on hyaluronidase activity.

3.2 透明質酸酶譜之電泳分析3.2 Electrophoretic analysis of hyaluronidase

同2.2所述方式,備妥含最終濃度0.017%之透明質酸(hyaluronic acid,Sigma-Aldrich,USA)的10.0%硫酸十二酯鈉-聚丙烯胺凝膠(SDS-PAGE)之分離膠體以及焦集膠體後,拔出電泳齒梳後,將鑄好的透明質酸-SDS-PAGE電泳膠片置於含有1X tank buffer(含25mM Tris、192mM glycine及0.1% SDS,pH 8.3)的電泳槽中。然後,將待測樣品與等體積之2倍濃縮追蹤染劑〔2X loading dye,含有溴酚藍(Bromophenol Blue,Amresco,USA)與甘油(J.T.Baker,USA)的混合溶液〕混合均勻,在每個焦集膠體的溝槽注入20μL之混合染劑的待測樣品,在80V電壓進行電泳,待膠片上的追蹤染劑離開堆疊膠體時,將電壓提高至100V進行電泳。待追蹤染劑移動到分離膠體底部後約40分鐘,結束電泳,取出透明質酸-SDS-PAGE電泳膠片。 Separating colloids containing 10.0% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) containing a final concentration of 0.017% hyaluronic acid (Sigma-Aldrich, USA) as described in 2.2 After collecting the gel, after extracting the electrophoresis comb, the cast hyaluronic acid-SDS-PAGE electrophoresis film was placed in an electrophoresis tank containing 1X tank buffer (containing 25 mM Tris, 192 mM glycine and 0.1% SDS, pH 8.3). . Then, the sample to be tested is mixed with an equal volume of 2 times concentrated dyeing agent [2X loading dye, a mixed solution containing Bromophenol Blue (Amresco, USA) and glycerol (JT Baker, USA)], A sample of the coke-colloid colloid was injected with 20 μL of the mixed sample of the dye, and electrophoresis was carried out at a voltage of 80 V. When the trace dye on the film left the stacked colloid, the voltage was raised to 100 V for electrophoresis. After about 40 minutes of moving the dye to be traced to the bottom of the separation gel, the electrophoresis was terminated, and the hyaluronic acid-SDS-PAGE electrophoresis film was taken out.

之後,將透明質酸-SDS-PAGE電泳膠片利用清洗緩衝液(wash buffer;含0.05M Tris、0.1M NaCl及2.5% Triton X-100)在37℃搖晃清洗1小時後,依序利用反應緩衝液(reaction buffer;含0.02M Sodium acetate-acetic acid及0.135M NaCl)於室溫(即10℃至40℃)搖晃反應20小時、0.5%之阿爾新藍(Alcian blue;Sigma,USA)溶液於室溫染色2小時、以及利用褪染緩衝液(含40%甲醇及7%醋酸)褪染1小時至2小時,直到透明的 色帶清晰可見為止。而後,利用玻璃紙封片固定於壓克力板上,放置室溫下自然風乾,其結果如圖5至圖7所示。 Thereafter, the hyaluronic acid-SDS-PAGE electrophoresis film was washed with a washing buffer (containing 0.05 M Tris, 0.1 M NaCl, and 2.5% Triton X-100) at 37 ° C for 1 hour, and then the reaction buffer was sequentially used. The reaction buffer (containing 0.02 M sodium acetate-acetic acid and 0.135 M NaCl) was shaken at room temperature (ie, 10 ° C to 40 ° C) for 20 hours, and a 0.5% solution of Alcian blue (Sigma, USA) was applied. Dye at room temperature for 2 hours, and fade with a fade buffer (containing 40% methanol and 7% acetic acid) for 1 hour to 2 hours until transparent The ribbon is clearly visible. Then, it was fixed on an acrylic plate with a cellophane sheet, and left to stand at room temperature to be air-dried. The results are shown in Figs. 5 to 7.

請參閱圖5至圖7,其係顯示本發明數個實施例之利用不同濃度的菱角殼水萃取液以不同時間與透明質酸酶反應後之透明質酸酶譜電泳分析圖。在圖5中,第1~4道代表透明質酸酶經序列稀釋(50X、100X、200X)之結果,其中1X代表原始濃度的透明質酸酶。第5道代表蛋白質標記(PageRulerTM Prestained Protein Ladder#26616,Thermo,USA;M),第6道代表控制組與透明質酸酶反應0小時(C0),第11道代表控制組與透明質酸酶反應24小時(C24)的結果,第16道代表控制組與透明質酸酶反應48小時(C48)的結果,第7~10道代表實驗組與透明質酸酶反應24小時的結果,第12~15道代表實驗組與透明質酸酶反應48小時的結果。 Please refer to FIG. 5 to FIG. 7 , which are diagrams showing the analysis of hyaluronic acid zymography after reacting different concentrations of water extract of water chestnut shell with hyaluronidase at different times according to several embodiments of the present invention. In Figure 5, lanes 1 through 4 represent the results of sequence dilution (50X, 100X, 200X) of hyaluronidase, where 1X represents the original concentration of hyaluronidase. Representative of five protein marker (PageRuler TM Prestained Protein Ladder # 26616 , Thermo, USA; M), the first representative of the control group and six hyaluronidase 0 hours reaction (C 0), the control section 11 representative of the hyaluronic group As a result of the acidase reaction for 24 hours (C 24 ), the 16th channel represents the result of the control group reacting with hyaluronidase for 48 hours (C 48 ), and the 7th to 10th channels represent the experimental group reacting with hyaluronidase for 24 hours. As a result, the 12th to 15th rows represent the results of the experimental group reacting with hyaluronidase for 48 hours.

在圖6至圖7中,第1道及第9道代表蛋白質標記(PageRulerTM Prestained Protein Ladder#26616,Thermo,USA;M),第2道代表控制組與透明質酸酶反應0小時(C0),第5道代表控制組與透明質酸酶反應24小時(C24)的結果,第8道代表控制組與透明質酸酶反應48小時(C48)的結果,第3、4道代表實驗組與透明質酸酶反應24小時的結果,第6、7道代表實驗組與透明質酸酶反應48小時的結果。 In FIG. 6 to FIG. 7, lane 1 represents a protein marker and 9 (PageRuler TM Prestained Protein Ladder # 26616 , Thermo, USA; M), lane 2 representing the control group and 0 hours reaction hyaluronidase (C 0 ), the fifth lane represents the result of the control group reacting with hyaluronidase for 24 hours (C 24 ), and the eighth lane represents the result of the control group reacting with hyaluronidase for 48 hours (C 48 ), lanes 3 and 4 Representing the results of the experimental group reacting with hyaluronidase for 24 hours, lanes 6 and 7 represent the results of the experimental group reacting with hyaluronidase for 48 hours.

由圖5的結果可知,利用0.25%的實施例之菱角殼水萃取液與透明質酸酶反應24小時後,即具有明顯抑制 透明質酸酶活性的效果。隨著菱角殼水萃取液之濃度以及反應時間的增加,抑制透明質酸酶活性的效果仍非常明顯,如圖5至圖7的結果所示。 It can be seen from the results of FIG. 5 that after 0.25% of the water extract of the water chestnut shell of the example was reacted with hyaluronidase for 24 hours, it was significantly inhibited. The effect of hyaluronidase activity. As the concentration of the water extract of the water chestnut shell and the reaction time increase, the effect of inhibiting the hyaluronidase activity is still very significant, as shown by the results of FIGS. 5 to 7.

相較之下,控制組的透明質酸酶活性並未受到抑制。因此,圖5至圖7的結果證明,實施例之菱角殼水萃取液確實可於體外抑制透明質酸酶活性。 In contrast, the hyaluronidase activity of the control group was not inhibited. Therefore, the results of Figures 5 to 7 demonstrate that the water extract of the water chestnut shell of the examples does inhibit the hyaluronidase activity in vitro.

綜言之,本發明之菱角殼水萃取液具有體外抑制MMP-2、MMP-9以及透明質酸酶活性,可作為MMP-2抑制劑、MMP-9以抑制劑以及透明質酸酶抑制劑,進而應用於製備各種皮膚外用組成物或醫藥組成物。 In summary, the water extract of the water chestnut shell of the present invention inhibits MMP-2, MMP-9 and hyaluronidase activity in vitro, and can be used as an MMP-2 inhibitor, an inhibitor of MMP-9 and a hyaluronidase inhibitor. Further, it is applied to the preparation of various skin external compositions or pharmaceutical compositions.

惟需補充的是,本發明雖以特定品種及部位的菱角殼、特定的萃取設備及條件、特定濃度的菱角殼水萃取液、特定的測試細胞、特定的分析方法或特定儀器作為例示,說明本發明之菱角殼水萃取液、其製造方法及其應用於作為MMP-2抑制劑、MMP-9以抑制劑以及透明質酸酶抑制劑,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此。在不脫離本發明之精神和範圍內,本發明之菱角殼水萃取液及其製造方法亦可使用其他濃度的菱角殼水萃取液、其他的萃取設備及條件、其他的測試細胞、其他的分析方法或其他儀器進行,進而應用至其他用途。 However, it should be added that the present invention exemplifies a specific variety and location of the water chestnut shell, specific extraction equipment and conditions, specific concentration of water chestnut shell water extract, specific test cells, specific analytical methods or specific instruments. The water extract of the water chestnut shell of the present invention, a method for producing the same, and the same are applicable as an MMP-2 inhibitor, an inhibitor of MMP-9, and a hyaluronidase inhibitor, but any one of ordinary skill in the art to which the present invention pertains is known. The present invention is not limited to this. The water chestnut shell water extract of the present invention and the method for producing the same can also use other concentrations of water chestnut shell water extract, other extraction equipment and conditions, other test cells, and other analysis without departing from the spirit and scope of the present invention. Method or other instrumentation, and then applied to other uses.

由上述本發明實施例可知,本發明之菱角殼水萃取液及其製造方法,其優點在於利用單步驟熱迴流萃取步驟,在100℃以及pH 7.0之水中處理紅菱角殼不超過3小時,以獲得粗萃物,再經去除不溶物後,獲得菱角殼水萃取 液。所得的。由此所得的菱角殼水萃取液經體外實驗證明具有體外抑制MMP-2、MMP-9以及透明質酸酶活性,可作為MMP-2抑制劑、MMP-9以抑制劑以及透明質酸酶抑制劑,進而應用於製備各種皮膚外用組成物或醫藥組成物,惟此處僅為例示說明用,本發明不限於此處所舉。 It can be seen from the above embodiments of the present invention that the water extract of the water chestnut shell of the present invention and the method for producing the same have the advantages of using a single-step hot reflux extraction step to treat the red cube shell in water at 100 ° C and pH 7.0 for no more than 3 hours. Obtaining the crude extract, and then removing the insoluble matter, obtaining the water extract of the water chestnut shell liquid. The resulting. The thus obtained water extract of water chestnut shell has been proved to inhibit MMP-2, MMP-9 and hyaluronidase activity in vitro, and can be inhibited as MMP-2 inhibitor, MMP-9 inhibitor and hyaluronidase. The agent is further applied to the preparation of various skin external compositions or pharmaceutical compositions, but is merely illustrative here, and the present invention is not limited thereto.

雖然本發明已以數個實施例揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described above in terms of several embodiments, it is not intended to limit the scope of the invention, and the invention may be practiced in various embodiments without departing from the spirit and scope of the invention. The scope of protection of the present invention is defined by the scope of the appended claims.

Claims (10)

一種菱角殼水萃取液之製造方法,包含:進行一單步驟熱迴流萃取步驟,利用100℃以及pH 7.0之水處理紅菱(Trapa bicornis var.taiwanensis(Nakai))殼不超過3小時,以獲得一粗萃物;以及進行一固液分離步驟,以去除該粗萃物之一不溶物,以獲得該菱角殼水萃取液。 A method for producing a water extract of a water chestnut shell, comprising: performing a single-step hot reflux extraction step, treating a shell of Trapa bicornis var. taiwanensis (Nakai) with water at 100 ° C and pH 7.0 for no more than 3 hours to obtain a crude extract; and performing a solid-liquid separation step to remove one of the crude extract insolubles to obtain the water extract of the water chestnut shell. 根據申請專利範圍第1項所述之菱角殼水萃取液之製造方法,其中該紅菱角殼與該水之一重量體積比(w/v;g/mL)為1:5至1:20。 The method for producing a water chestnut shell water extract according to claim 1, wherein the weight ratio of the red cube shell to the water (w/v; g/mL) is 1:5 to 1:20. 根據申請專利範圍第1項所述之菱角殼水萃取液之製造方法,其中該紅菱角殼與該水之一重量體積比(w/v;g/mL)為1:5至1:10。 The method for producing a water chestnut shell water extract according to claim 1, wherein the weight ratio of the red cube shell to the water (w/v; g/mL) is 1:5 to 1:10. 根據申請專利範圍第1項所述之菱角殼水萃取液之製造方法,其中該紅菱角殼與該水之一重量體積比(w/v;g/mL)為1:5至1:8。 The method for producing a water chestnut shell water extract according to claim 1, wherein the weight ratio of the red cube shell to the water (w/v; g/mL) is 1:5 to 1:8. 根據申請專利範圍第1項所述之菱角殼水萃取液之製造方法,其中在該單步驟熱迴流萃取步驟之前,更至少包含:對該紅菱角殼進行一乾燥處理;以及對經乾燥之該紅菱角殼進行一研磨處理,以獲得一菱角殼乾燥粉末。 The method for producing a water extract of a water chestnut shell according to claim 1, wherein before the single-step hot reflux extraction step, at least comprising: drying the red cube shell; and drying the shell The red horn shell is subjected to a grinding treatment to obtain a dry powder of a water chestnut shell. 根據申請專利範圍第1項所述之菱角殼水萃取液之製造方法,其中該熱迴流萃取步驟進行1小時至3小時。 The method for producing a water chestnut shell water extract according to claim 1, wherein the hot reflux extraction step is performed for 1 hour to 3 hours. 一種菱角殼水萃取液,其係由申請專利範圍第1項至第6項任一項所述之方法所製得,其中該菱角殼水萃取液具有抑制第二型基質金屬蛋白酶(MMP-2)及/或第九型基質金屬蛋白酶(MMP-9)之一活性。 An aqueous extract of water chestnut shell obtained by the method according to any one of claims 1 to 6, wherein the water extract of the water chestnut shell has a second type of matrix metalloproteinase (MMP-2). And/or one of the ninth type of matrix metalloproteinase (MMP-9) is active. 一種體外抑制基質金屬蛋白酶之方法,其特徵在於利用含有如申請專利範圍第7項所述之菱角殼水萃取液之一組成物於體外處理一動物細胞,以抑制該動物細胞之第二型基質金屬蛋白酶及/或第九型基質金屬蛋白酶的一活性。 A method for inhibiting a matrix metalloproteinase in vitro, which comprises treating an animal cell in vitro with a composition comprising a water extract of a water chestnut shell as described in claim 7 to inhibit a second type matrix of the animal cell An activity of a metalloproteinase and/or a ninth type matrix metalloproteinase. 根據申請專利範圍第8項所述之體外抑制基質金屬蛋白酶之方法,其中該動物細胞之一來源為小鼠,且該動物細胞為纖維母細胞。 The method for inhibiting a matrix metalloproteinase in vitro according to the invention of claim 8, wherein one of the animal cells is derived from a mouse, and the animal cell is a fibroblast. 根據申請專利範圍第8項所述之體外抑制基質金屬蛋白酶之方法,其中該組成物為一皮膚外用組成物或一醫藥組成物。 The method for inhibiting a matrix metalloproteinase in vitro according to the invention of claim 8, wherein the composition is a skin external composition or a pharmaceutical composition.
TW104108491A 2015-03-17 2015-03-17 Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof TWI546085B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW104108491A TWI546085B (en) 2015-03-17 2015-03-17 Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104108491A TWI546085B (en) 2015-03-17 2015-03-17 Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof

Publications (2)

Publication Number Publication Date
TWI546085B TWI546085B (en) 2016-08-21
TW201634043A true TW201634043A (en) 2016-10-01

Family

ID=57183751

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104108491A TWI546085B (en) 2015-03-17 2015-03-17 Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof

Country Status (1)

Country Link
TW (1) TWI546085B (en)

Also Published As

Publication number Publication date
TWI546085B (en) 2016-08-21

Similar Documents

Publication Publication Date Title
CN102349867B (en) Water-replenishing repairing cosmetic as well as preparation method and application thereof
CN102821750B (en) Preparation, its purposes and its production for being used to treat skin aging, inflammation and scar caused by vitro culture from the Ci Agan tree cells of induction dedifferente, non-
CN106397629B (en) Method, the chondroitin sulfate by this method extraction and the application of chondroitin sulfate are extracted from sturgeon fish-bone
CN106755228A (en) The technique for preparing the oligomeric Gly-His-Lys of selenium yeast using Se-enriched yeast
US11279962B2 (en) Chitin and chitosan producing methods
CN106031709A (en) Milt DNA-NA, protamine extract and preparing method thereof
CN103882083A (en) Method for preparing antioxidant collagen peptide
CN103169942A (en) Enzymolysis method for preparing velvet antler collagen
JPH0741426A (en) Active oxygen scavenger from rice
CN104803714B (en) Animal source waste converted products, its preparation method and application
CN105420325A (en) Placenta polypeptide preparation method
CN100467061C (en) Scorpionfish-ink polysaccharide and its preparation
CN102971415B (en) PDGF-BB produces reinforcing agent and the mesenchyme lineage stem cells generation accelerator, stem cell stabilizer and the corium regenerative agent that comprise this reinforcing agent
TWI546085B (en) Aqueous extract liquid of water calltrop shell, method of producing the same and applications thereof
CN102321569B (en) Method for constructing Kareius bicoloratus liver cell line
US20210393501A1 (en) Preparation method and application of recombinant mutant collagenase
TWI564028B (en) Use of eustoma grandiflorum extract
CN107488696A (en) One breeder bone double enzymolysis method
CN105200107B (en) The extracting method of Onchidium struma muscle crude protein
CN108486201B (en) Method for extracting bioactive polypeptide of ginkgo
CN113519857A (en) Acer truncatum peptide powder rich in nervonic acid and preparation method thereof
JP5937450B2 (en) Hyaluronidase inhibitor
RU2625497C1 (en) Method for manufacturing food additive from wild plant of lupin
CN105255981A (en) Non-degenerated jellyfish collagen preparation method
CN104509914A (en) Production method of collagen beverage

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees